PLIVA 789
Pill imprint PLIVA 789 has been identified as Azithromycin 600 mg.
Azithromycin is used in the treatment of bronchitis; upper respiratory tract infection; bacterial infection; sinusitis; pneumonia (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy.
Azithromycin 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Azithromycin Images
- Imprint:
-
PLIVA
789 - Strength:
- 600 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Macrolides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Pliva Inc.
Advertisement
More Azithromycin resources
- Azithromycin
- Azithromycin (Wolters Kluwer)
- Azithromycin Extended-Release Oral Suspension (Wolters Kluwer)
- Azithromycin Single-Dose Packet (Wolters Kluwer)
- Azithromycin Suspension (Wolters Kluwer)
- Azithromycin Tablets (Wolters Kluwer)
- azithromycin (Cerner Multum)
- azithromycin (Micromedex) - Includes Dosage Information
- azithromycin Intravenous (Micromedex) - Includes Dosage Information
- Azithromycin (AHFS DI)
- Azithromycin Injection (FDA)
- Azithromycin Oral Suspension (FDA)
- Azithromycin Tablets (FDA)
- Zithromax Injection (FDA)
Azithromycin is associated with the treatment of:
- Babesiosis
- Bacterial Endocarditis Prevention
- Bacterial Infection
- Bartonellosis
- Bronchitis
- Cervicitis
- Chancroid
- COPD, Acute
- Cystic Fibrosis
- Gonococcal Infection, Uncomplicated
- Granuloma Inguinale
- Legionella Pneumonia
- Lyme Disease, Erythema Chronicum Migrans
- Mycobacterium avium-intracellulare, Prophylaxis
- Mycobacterium avium-intracellulare, Treatment
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Otitis Media
- Pelvic Inflammatory Disease
- Pharyngitis
- Pneumonia
- Sinusitis
- Skin Infection
- Tonsillitis/Pharyngitis
- Toxoplasmosis
- Typhoid Fever
- Upper Respiratory Tract Infection
Search Again
